References
Leizorovicz A, Boissel JP (1983) Oral anticoagulant in patients surviving myocardial infarction: A new approach to old data. Eur J Clin Pharmacol 24: 333–336
Bjerkelund CJ (1957) The effect of long-term treatment with dicoumarol in myocardial infarction. Acta Med Scand 158: 158 [Suppl 330]: 13–212
Borchgrevink CF (1960) Long-term anticoagulant therapy in angina pectoris and myocardial infarction. Acta Med Scand 359: [Suppl] 7–52
Britisch Medical Research Council (1964) An assessment of long-term anticoagulant administration after cardiac infarction. Br Med J 2: 837–843
Aspenstrøm G, Korsan-Bengtsen K (1964) A double-blind study of dicumarol prophylaxis in coronary heart disease. Acta Med Scand 176: 563–575
Rozenberg MC, Kronenberg H, Firkin BG (1965) “Thrombotest” and prothrombin time: a controlled clinical trial. Ann Med 14: 3–12
Loeliger EA, Hensen A, Kroes F et al. (1967) A double-blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 182: 549–566
Meuwissen OJAT, Vervoorn AC, Cohen O et al. (1969) Double blind trial of long-term anticoagulant treatment after myocardial infarction. Acta Med Scand 186: 361–368
Sørensen OH, Friis T, Jørgensen AW et al. (1969) Anticoagulant tratment of acute coronary thrombosis. Acta Med Scand 185: 65–72
Sixty Plus Reinfarction Study Research Group (1982) Risks of long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1: 64–68
MacMillan RL, Brown KGW, Watt DL (1960) Long-term anticoagulant therapy after ymocardial infarction. Can Med Asoc J 83: 567–570
Harvald B, Hilden T, Lund E (1962) Long-term anticoagulant therapy after myocardial infarction. Lancet 2: 626–630
Clausen J, Andersen PE, Andresen P et al. (1961) Langtids-antikoagulansbehandling efter akut hjerteinfarkt. Ugeskr Laeger 123: 973–983
Conrad LL, Kryiacopoulos JD, Wiggins CW et al. (1964) Prevention of recurrences of myocardial infarction. Arch Int Med 114: 348–358
Lovell RHH, Denborough MA, Nestel PJ et al. (1967) A controlled trial of long-term treatment with anticoagulant after myocardial infarction in 412 male patients. Med J Austral 2: 97–104
Ebert RV, Borden CW, Hipp HR et al. (1969) Long-term anticoagulant therapy after myocardial infarction. J Am Med Assoc 207: 2263–2267
Seaman AJ, Griswold HE, Beaume RB et al. (1969) Long-term anticoagulant prophylaxis after myocardial infarction. N Engl J Med 281: 115–119
Ritland S, Lygren T (1969) Comparison of efficacy of 3 and 12 months' anticoagulant therapy after myocardial infarction. Lancet 1: 122–124
Breddin K, Loew D, Lechner K et al. (1980) Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. Haemostasis 9: 325–344
EPSIM Research Group (1982) A controlled comparison of aspirin and oral anticoagulants in prevention of death after myocardial infarction. N Engl J Med 307: 701–708
Merskey C, Drapkin A (1974) Long-term anticoagulant therapy after myocardial infarction (Letter). J Am Med Assoc 230: 208–209
Baptista J, Pike MC (1977) Exact two-sided confidence limits for the odds ration in a 2 × 2 table. Appl Stats 26: 214–220
Thomas DG, Gart JJ (1977) A table of exact confidence limits for differences and ratios of two proportions and their odds ratio. J Stat Assoc 72: 73–76
Loeliger EA, Lewis SM (1982) Progress in laboratory control of oral anticoagulants. Lancet 2: 318–320
References
Boissel JP, Meunier P (1971) Pour un enseignement de l'expression médicale et scientifique. III Information et essais thérapeutiques. 2. Quelques critères utiles pour juger la validité d'un essai thérapeutique. Lyon-Med 226 [20] 807–812
Chalmers ThC, Smith H Jr, Blackburn B, Silverman B, Schroeder B, Reitman D, Ambroz A (1981) A method for assessing the quality of a randomized control trial. Controlled Clin Trials 2 [1] 31–490
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loeliger, E.A., Leizorovicz, A. Oral anticoagulation in patients surviving myocardial infarction. A new approach to old data. Eur J Clin Pharmacol 26, 137–141 (1984). https://doi.org/10.1007/BF00546723
Issue Date:
DOI: https://doi.org/10.1007/BF00546723